Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
U-500 Insulin via Omnipod in T2D with Severe Insulin Resistance
NCT00606034Phase 4Completed
- Sponsor
- Mountain Diabetes and Endocrine Center
- Start
- Dec 2007
- Primary completion
- Jul 2009
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of regular human insulin in type 2 diabetes mellitus (T2DM) and insulin resistance (IR), sponsored by Mountain Diabetes and Endocrine Center. Primary endpoint: Change in Hemoglobin A1c at 1 year. Started Dec 2007; status: completed.
02
Drugs
regular human insulin
03
Conditions
type 2 diabetes mellitus (T2DM)insulin resistance (IR)
Beyond the preview
Go deeper on NCT00606034.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00606034.